EverHint – Momentum Swing — Explosive Volume Breakout for Mar 25, 2026 – 2 Signals – Technology Leads (1)
What This Signal Is (Quick)
Explosive Volume Breakout is a momentum swing trading strategy focused on Breakouts with 2.5x+ volume surge - institutional buying pressure.
Signal Type: Breakout (momentum continuation)
What Makes This Signal:
- Stock showing strong momentum near or at highs
- Increased volume confirms institutional interest
- Breaking out or consolidating near resistance
- Breakouts with 2.5x+ volume surge - institutional buying pressure
Ideal For: Traders seeking breakouts with exceptional volume confirmation
Key Criteria:
-
Strong RSI momentum (configurable thresholds)
-
Volume surge above average
-
Price momentum confirmation
-
Minimum ADV: $25M+ (varies by variant)
-
Earnings buffer: 7 days pre/post earnings
-
Variant-specific filters applied
Holding Period: 1-4 weeks
Risk Level: Medium-High
How We Ranked Today
Ranked by composite momentum score (higher = stronger momentum)
📊 Momentum Swing — Explosive Volume Breakout Signals (2 Total)
Ranked by score:
| Rank | Ticker | Company | Sector | Last ($) | Score | Vol Thrust | @52w | Insider Net | Days → Earnings | Est EPS | Mkt Cap ($B) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | DOCN | DigitalOcean Holdings,... | Technology | 87.02 | 0.300 | 3.50x | 0.0% | — | 40 | $2.79 | 8.0 |
| 2 | TERN | Terns Pharmaceuticals,... | Healthcare | 52.86 | 0.000 | 12.78x | 0.0% | $-3.0M | — | $-1.63 | 4.8 |
Field Notes
Sector concentration: Technology (1), Healthcare (1)
Insider selling: TERN (Terns Pharmaceuticals, Inc., $-3.0M)
Data coverage: 50.0% insider, 0.0% congressional, 50.0% earnings, 100.0% analyst, 50.0% news
Peer Analysis
Understanding how these stocks relate to their industry peers:
DOCN (DigitalOcean Holdings, Inc.): Leads 10 peers: DLO ($13.02, +0.8%), SPSC ($55.00, -2.3%), VRNS ($21.39, -2.8%), CLBT ($14.16, -0.3%), QLYS ($89.90, -2.6%) | Peer of: AVT ($62.26, +1.7%), BOX ($23.66, +0.2%), CLBT ($14.16, -0.3%) and 10 more
TERN (Terns Pharmaceuticals, Inc.): Leads 9 peers: ORIC ($11.70, +5.4%), PGEN ($3.10, -1.0%), IMTX ($9.74, +5.9%), ELVN ($35.53, +14.1%), AMLX ($13.83, +1.2%) | Peer of: BBNX ($11.31, +0.6%), IMTX ($9.74, +5.9%), KMTS ($20.58, -0.6%) and 7 more
Recent Headlines
TERN (Terns Pharmaceuticals, Inc.)
- Terns Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Terns Pharmaceuticals, Inc. - TERN (source)
- $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Terns Pharmaceuticals, Inc. (NASDAQ: TERN) (source)
- Nasdaq, Dow Jones finish session ahead, oil price softens as US pushes for Iran peace talks (source)
- Dow, Nasdaq Higher Despite U.S.-Iran Peace Deal Uncertainty (source)
- Merck's $6.7 Billion Terns Pharmaceuticals Acquisition May Face Rival Interest: Analyst (source)
- Merck to acquire Terns Pharmaceuticals for $6.7B (source)
- Shareholder Alert: The Ademi Firm investigates whether Terns Pharmaceuticals Inc. is obtaining a Fair Price for Public Shareholders (source)
- TERN Stock Alert: Halper Sadeh LLC is Investigating Whether Terns Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders (source)
- Merck to buy Terns Pharmaceuticals for $6.7 billion to boost cancer pipeline (source)
- Merck boosts cancer portfolio with $6.7 billion buyout of Terns Pharma (source)
- Merck Reaches Nearly $6 Billion Deal for Cancer Biotech Terns (source)
- Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML) (source)
- Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML) (source)
- Merck nears $6 billion all-cash deal to buy Terns Pharma, FT reports (source)
- As Terns Stock Soars 1,400%, What Does One Fund's $5.2 Million Sale Signal to Investors? (source)
- Terns Pharmaceuticals (NASDAQ:TERN) Reaches New 1-Year High – Should You Buy? (source)
- This Biotech Fund Sold $8 Million of Terns Stock Last Quarter, but Here's Why It Still Seems Very Bullish (source)
Market Context
Broad market indices are exhibiting modest gains, with the Nasdaq leading at +0.75%, followed by the Dow Jones at +0.66% and S&P 500 at +0.54%. This upward trend signals positive risk appetite, fostering an environment conducive to momentum swing strategies that rely on explosive volume breakouts. The Technology sector's prominence among signals aligns with the Nasdaq's relative strength, suggesting potential sector rotation favoring growth-oriented areas amid this bullish breadth.
The VIX at 25.34, down sharply by 5.97%, indicates contracting volatility from recent highs, which tempers extreme intraday swings while still providing sufficient choppiness for breakout opportunities. For momentum swing explosive volume breakouts, this setup reduces whipsaw risk, allowing high-volume moves to sustain in a trending market without excessive noise. Declining fear levels further bolster conviction in upward momentum plays.
Overall, current conditions support this strategy's efficacy, as stabilizing volatility and risk-on sentiment enhance the reliability of breakouts, particularly in leading sectors. Traders should monitor for sustained volume confirmation to navigate any residual intraday fluctuations effectively.
Sharing Call-to-Action
🚀 Support the project by liking, sharing, or subscribing — it helps more readers discover these signals.
Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.
This is not financial advice. Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/